[EN] USE OF DDX3 INHIBITORS AS ANTIPROLIFERATIVE AGENTS<br/>[FR] UTILISATION D'INHIBITEURS DE DDX3 EN TANT QU'AGENTS ANTIPROLIFÉRATIFS
申请人:AZIENDA OSPEDALIERA UNIV SENESE
公开号:WO2017162834A1
公开(公告)日:2017-09-28
The present invention refers to compounds of formula I or II endowed with DDX3 inhibitory activity, relative pharmaceutical compositions and their use as antihyperproliferative agents. (I) or (II)
[EN] HUMAN HELICASE DDX3 INHIBITORS AS THERAPEUTIC AGENTS<br/>[FR] INHIBITEURS D'HÉLICASE DDX3 HUMAINE COMME AGENTS THÉRAPEUTIQUES
申请人:AZIENDA OSPEDALIERA UNIV SENESE
公开号:WO2016128541A1
公开(公告)日:2016-08-18
The present invention refers to compounds endowed with RNA helicase DDX3 inhibitory activity of formula I and II and their therapeutic use, in particular for the treatment of viral diseases.
Electrochemical initiation of radical chain addition of F-n butyl iodide to acetylenic alcohols. Cyclic voltammetric investigation of the mechanism
作者:P. Calas、C. Amatore、L. Gomez、A. Commeyras
DOI:10.1016/s0022-1139(00)80384-x
日期:1990.8
initiation of the radical chain addition of F-n butyl iodide to alkynols through the cathodic reduction of the halide at a carbon cathode is presented. A simplified analysis, based on cyclic voltammetry affords an estimation of the ratio of the rate constants of the two propagation steps, addition of Rf° to alkynol and iodine atom transfer from the F-alkyl iodide to the resulting vinyl radical, involved in
提出了通过在碳阴极上卤化物的阴极还原引发Fn丁基碘自由基向炔醇的自由基链加成反应。基于循环伏安法的简化分析提供了两个传播步骤速率常数比率的估算值,R f °添加到炔醇中,碘原子从F-烷基碘化物转移到生成的乙烯基,这涉及自由基链机制。
Radical chain addition of iodo-perfluoroalkanes to ethylenic or acetylenic substrates. Comparison of rates of iodine atom transfer from C4F9I to σ-vinyl and σ-alkyl α-F alkyl radicals
Under electrochemical activation, the addition of C4F9I to ethylenic or acetylenic substrates proceeds via a radical chain involving addition of C4F9− radicals to the multiple bond followed by iodine-atom transfer from C4F9I to the alkyl or vinyl α-F alkyl radical thus formed. Combined use of voltammetric and electrolytic techniques allows quantitative comparison of the reactivities of alkyl and vinyl
Human helicase DDX3 inhibitors as therapeutic agents
申请人:AZIENDA OSPEDALIERA UNIVERSITARIA SENESE
公开号:US10941121B2
公开(公告)日:2021-03-09
The present invention refers to compounds endowed with RNA helicase DDX3 inhibitory activity of formula I and II and their therapeutic use, in particular for the treatment of viral diseases.
本发明是指具有式 I 和 II 的 RNA 螺旋酶 DDX3 抑制活性的化合物及其治疗用途,特别是用于治疗病毒性疾病。